Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure.

Callanan EY, Lee EW, Tilan JU, Winaver J, Haramati A, Mulroney SE, Zukowska Z.

Am J Physiol Renal Physiol. 2007 Dec;293(6):F1811-7.

2.
3.
4.

Evidence for two neuropeptide Y receptors mediating vasoconstriction.

Modin A, Pernow J, Lundberg JM.

Eur J Pharmacol. 1991 Oct 15;203(2):165-71.

PMID:
1666044
6.

Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes.

Chottová Dvoráková M, Wiegand S, Pesta M, Slavíková J, Grau V, Reischig J, Kuncová J, Kummer W.

Neuroscience. 2008 Feb 19;151(4):1016-28. doi: 10.1016/j.neuroscience.2007.07.069.

PMID:
18201831
7.

Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.

Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z.

Can J Physiol Pharmacol. 2003 Feb;81(2):177-85.

PMID:
12710532
8.

Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats.

Zhao XH, Sun XY, Bergdahl A, Edvinsson L, Hedner T.

J Pharm Pharmacol. 1999 Nov;51(11):1257-65.

PMID:
10632083
9.

Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.

Larsen PJ, Sheikh SP, Jakobsen CR, Schwartz TW, Mikkelsen JD.

Eur J Neurosci. 1993 Dec 1;5(12):1622-37.

PMID:
8124516
10.

NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs.

Mahns DA, Kelly C, McCloskey DI, Potter EK.

J Auton Nerv Syst. 1999 Oct 8;78(1):10-7.

PMID:
10589818
11.
13.

Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog.

Malmström RE, Hökfelt T, Björkman JA, Nihlén C, Byström M, Ekstrand AJ, Lundberg JM.

Regul Pept. 1998 Sep 25;75-76:55-70.

PMID:
9802394
14.

[Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist.

Fuhlendorff J, Gether U, Aakerlund L, Langeland-Johansen N, Thøgersen H, Melberg SG, Olsen UB, Thastrup O, Schwartz TW.

Proc Natl Acad Sci U S A. 1990 Jan;87(1):182-6.

15.

Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.

Bischoff A, Avramidis P, Erdbrügger W, Münter K, Michel MC.

Br J Pharmacol. 1997 Apr;120(7):1335-43.

16.

Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.

Francis B, Winaver J, Karram T, Hoffman A, Abassi Z.

J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S54-8.

PMID:
15838359
18.

Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure.

Winaver J, Ovcharenko E, Rubinstein I, Gurbanov K, Pollesello P, Bishara B, Hoffman A, Abassi Z.

Am J Physiol Heart Circ Physiol. 2006 May;290(5):H2007-14.

19.
20.

Supplemental Content

Support Center